Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2005, Pages 260-266

  Heslop, Helen E ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

ARTICLE; CHEMICALLY INDUCED DISORDER; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENETICS; GRAFT REJECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOLOGY; IMMUNOTHERAPY; LYMPHOPROLIFERATIVE DISEASE; METHODOLOGY; NONHODGKIN LYMPHOMA; PHYSIOLOGY; TRANSPLANTATION; VIROLOGY; VIRUS LATENCY;

EPSTEIN-BARR VIRUS INFECTIONS; GRAFT REJECTION; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; METHOTREXATE; TRANSPLANTATION; VIRUS LATENCY;

EID: 33646118700     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2005.1.260     Document Type: Article

References (0)